Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Raptor Pharmaceuticals Corp. (2) Acquired (2)
cysteamine (cystagon) (2 trials)
fomepizole (antizol) (1 trial)
ngx267 (1 trial)
tezampanel (1 trial)
Key: Raptor Pharmaceuticals Corp. (0) Acquired (1)
ngx426 (1 trial)
Fatty Liver (Phase 2)
Trials (6 total)
Trial APIs (5 total)